Eric Topol's Interviews
The Challenges and Benefits of Generative AI in Health Care
Artificial Intelligence is on every business leader’s agenda. How do we make sense of the fast-moving new developments in AI over the past year? Azeem Azhar returns to bring clarity to leaders who face a complicated information landscape. Generative AI has a lot to offer health care professionals and medical scientists
With the national state of emergency for Covid-19 now officially over, we invited physician and author Topol to reflect on his experience writing a regular online newsletter attempting to counter the misinformation flooding the internet. Called Ground Truths, it takes an unsparing dive into what went right and what wen
Eric Topol is a leading health expert whose writing and explainers about Covid-19 have helped people better understand the complexities of the global pandemic. As a doctor, author, and one of the most cited researchers in medicine, Eric has dedicated his time to thinking about the human genome and how digital tools lik
Eric Topol || Public Service Announcement: Separating Facts from Myths in the Pandemic
It's important to recognize that when we're dealing with a very new or rapidly changing phenomenon, like we have been with the pandemic, even the "scientific consensus" can easily be wrong because there's not been much time for the rigorous replicability studies to be conducted or even sometimes to accurately measure t
In this episode of “Keen On”, Andrew is joined by Dr. Eric Topol, Substack's newest writer in residence. Eric Topol is an American cardiologist, scientist, and award winning author. He is the founder and director of the Scripps Research Translational Institute and a senior consultant at the Division of Cardiovascular D
Sam Harris speaks with Eric Topol about vaccine hesitancy and related misinformation. They discuss the problem of political and social siloing, concerns about mRNA vaccines, the Emergency Use Authorization by the FDA, the effectiveness of the COVID vaccines, vaccine efficacy vs effectiveness, the Delta variant, the mis
Shout-outs
Add shout-out